ATM is the most frequently mutated DNA damage repair gene in NSCLC (approximately 3% of samples), and is significantly associated with mutations in KRAS, but mutually exclusive with EGFR mutations (40). This evidence concerns the gene ATM and non-small cell lung carcinoma.